Company
Headquarters: London, United Kingdom
Employees: 4
CEO: Mr. Trevor Taylor
No stock data available
€26.3 Million
EUR as of Jan. 1, 2024
US$29.0 Million
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Chill Brands Group PLC engages in the research, development, production, and sale of cannabidiol (CBD) consumer products and other lifestyle goods in the United States and the United Kingdom. The company offers tobacco alternative products, including smokes and chew pouches. It provides oral tinctures, soft-gel capsules, massage oils, and topical cosmetic products. The company was formerly known as Zoetic International Plc and changed its name to Chill Brands Group PLC in August 2021. Chill Brands Group PLC was incorporated in 2014 and is headquartered in London, the United Kingdom.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Chill Brands Group PLC has the following listings and related stock indices.
Stock: FSX: 7HR wb_incandescent
Stock: OTC: ZOEIF wb_incandescent